Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard Treatment or Topical Doxepin Against Pruritus in Burn Patients
2009-015090-12Phase 4Active
- Sponsor
- Association of Dutch Burn Centres
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of doxepin in pruritus and burn injury (2 arms), sponsored by Association of Dutch Burn Centres. Primary endpoint: Change in mean pruritus intensity. Started Jul 2013; status: active.
02
Drugs
doxepin
03
Conditions
pruritusburn injury
Beyond the preview
Go deeper on 2009-015090-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015090-12.